Greenwood Capital Associates LLC grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 29.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 27,925 shares of the financial services provider's stock after purchasing an additional 6,346 shares during the quarter. Greenwood Capital Associates LLC's holdings in CME Group were worth $6,167,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the stock. New Mexico Educational Retirement Board lifted its position in shares of CME Group by 8.5% during the second quarter. New Mexico Educational Retirement Board now owns 17,935 shares of the financial services provider's stock valued at $3,961,000 after buying an additional 1,400 shares during the last quarter. Royal London Asset Management Ltd. boosted its stake in CME Group by 30.4% in the second quarter. Royal London Asset Management Ltd. now owns 716,972 shares of the financial services provider's stock valued at $158,329,000 after acquiring an additional 167,126 shares in the last quarter. Mufg Securities Americas Inc. grew its holdings in CME Group by 9.4% in the second quarter. Mufg Securities Americas Inc. now owns 10,914 shares of the financial services provider's stock worth $2,410,000 after purchasing an additional 936 shares during the last quarter. Nissay Asset Management Corp Japan increased its position in shares of CME Group by 2.7% during the second quarter. Nissay Asset Management Corp Japan now owns 57,324 shares of the financial services provider's stock worth $12,659,000 after purchasing an additional 1,516 shares in the last quarter. Finally, Braun Stacey Associates Inc. lifted its holdings in shares of CME Group by 4.8% during the 2nd quarter. Braun Stacey Associates Inc. now owns 117,163 shares of the financial services provider's stock valued at $25,873,000 after purchasing an additional 5,398 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company's stock.
Insider Activity
In other news, Director William R. Shepard bought 325 shares of the firm's stock in a transaction that occurred on Thursday, June 25th. The shares were purchased at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. The trade was a 0.12% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 0.30% of the company's stock.
CME Group Trading Up 1.7%
CME stock opened at $285.80 on Friday. The business's 50-day moving average is $253.80 and its 200 day moving average is $279.13. CME Group Inc. has a 12-month low of $218.31 and a 12-month high of $329.16. The stock has a market cap of $102.77 billion, a price-to-earnings ratio of 24.24, a PEG ratio of 3.40 and a beta of 0.23. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME - Get Free Report) last announced its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating analysts' consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. During the same quarter last year, the firm posted $2.96 EPS. The firm's revenue for the quarter was up .8% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 12.27 EPS for the current fiscal year.
CME Group Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group's payout ratio is presently 44.11%.
Wall Street Analysts Forecast Growth
A number of equities research analysts have commented on the company. Raymond James Financial reiterated an "outperform" rating and issued a $320.00 price target on shares of CME Group in a research note on Thursday, July 2nd. Keefe, Bruyette & Woods raised CME Group from a "market perform" rating to an "outperform" rating and set a $305.00 price target for the company in a research report on Thursday, June 18th. TD Cowen cut their price objective on CME Group from $323.00 to $273.00 and set a "buy" rating on the stock in a report on Monday, June 22nd. Piper Sandler cut their price objective on shares of CME Group from $329.00 to $295.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 15th. Finally, The Goldman Sachs Group cut their price target on CME Group from $267.00 to $245.00 and set a "sell" rating on the stock in a research report on Tuesday, June 30th. Nine investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, CME Group has a consensus rating of "Hold" and an average target price of $288.56.
View Our Latest Stock Report on CME Group
About CME Group
(
Free Report)
CME Group Inc is a global markets company that operates some of the world's largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company's core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
